Join

Compare · MDLN vs NYXH

MDLN vs NYXH

Side-by-side comparison of Medline Inc. (MDLN) and Nyxoah SA (NYXH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both MDLN and NYXH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • MDLN is the larger of the two at $58.80B, about 451.9x NYXH ($130.1M).
  • Over the past year, MDLN is up 9.9% and NYXH is down 49.8% - MDLN leads by 59.7 points.
  • MDLN has hit the wire 5 times in the past 4 weeks while NYXH has been quiet.
  • MDLN has more recent analyst coverage (25 ratings vs 8 for NYXH).
PerformanceMDLN+9.87%NYXH-37.66%
2025-12-17+0.00%2026-04-24
MetricMDLNNYXH
Company
Medline Inc.
Nyxoah SA
Price
$44.77-3.05%
$2.98-2.93%
Market cap
$58.80B
$130.1M
1M return
+5.00%
-5.85%
1Y return
+9.87%
-49.83%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2025
2021
News (4w)
5
0
Recent ratings
25
8
NYXH

Nyxoah SA

Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.

Latest MDLN

Latest NYXH